sars-cov |
28 |
covid-19 |
27 |
sars-cov-2 |
24 |
viral replication |
20 |
influenza a virus |
16 |
antiviral |
14 |
hemagglutinin |
14 |
mers-cov |
14 |
animal experiment |
13 |
coronavirus |
13 |
cytokine and chemokine response |
13 |
disease outbreaks |
13 |
immune activation |
13 |
influenza virus |
13 |
intestine |
13 |
pathogenesis |
13 |
pathogenicity |
13 |
replication |
13 |
animal cell |
11 |
animal tissue |
11 |
bat |
11 |
coronavirus disease 2019 |
11 |
feces analysis |
11 |
adaptation |
10 |
anthranilic acid |
10 |
antigen-presentation |
10 |
broad spectrum |
10 |
coronavirus - immunology - pathogenicity - physiology |
10 |
coronavirus infections - immunology - virology |
10 |
cytokines - biosynthesis - immunology |
10 |
d222g |
10 |
d225g |
10 |
endoplasmic reticulum |
10 |
h1n1 |
10 |
hemagglutinin glycoproteins, influenza virus - genetics - metabolism |
10 |
human immunodeficiency virus |
10 |
influenza |
10 |
influenza a virus, h1n1 subtype - genetics - pathogenicity |
10 |
influenza, human - epidemiology - virology |
10 |
interferon |
10 |
mice |
10 |
mutation - genetics |
10 |
pandemic |
10 |
pneumonia, viral - immunology - virology |
10 |
polymorphism, single nucleotide |
10 |
sialic acid |
10 |
virus replication - physiology |
10 |
airway organoid |
9 |
human neutralizing antibody |
9 |
humans |
9 |
infectivity |
9 |
lung injury |
9 |
nasal turbinate |
9 |
pb2 |
9 |
phage display |
9 |
proximal differentiation |
9 |
receptor binding domain |
9 |
transmission |
9 |
upper respiratory tract |
9 |
2009 h1n1 influenza |
8 |
animal model |
8 |
antibody detection |
8 |
apoptosis |
8 |
bagg albino mouse |
8 |
caspase |
8 |
clinical outcome |
8 |
controlled study |
8 |
ex vivo |
8 |
female |
8 |
flavivirus |
8 |
ganglioside gm1 antibody |
8 |
genetic predisposition to disease |
8 |
influenza vaccine |
8 |
inhibitor |
8 |
male |
8 |
marmosets |
8 |
ns5 |
8 |
spleen |
8 |
t lymphocytes |
8 |
tonsil |
8 |
a(h1n1)pdm09 influenza |
7 |
a(h7n9) influenza |
7 |
alleles |
7 |
anti-influenza |
7 |
antibody-dependent cell-mediated cytotoxicity |
7 |
cross-protection |
7 |
cva16 |
7 |
ev-a71 |
7 |
furin cleavage prra motif |
7 |
genetic variation |
7 |
genome mutation |
7 |
h1n1 influenza virus |
7 |
hbv infection |
7 |
hepatitis b, chronic - genetics - immunology - metabolism |
7 |
human respiratory syncytial virus |
7 |
ifnar1 |
7 |
intestinal organoids |
7 |
lethal mouse model |
7 |
lung damage |
7 |
lung eqtl |
7 |
lung pathology |
7 |
polymerase assembly |
7 |
promoter regions, genetic |
7 |
receptor, interferon alpha-beta - genetics |
7 |
snp |
7 |
tmprss2 |
7 |
transcription regulation |
7 |
viral variants |
7 |
adult |
6 |
animals |
6 |
clr |
6 |
dendritic cells |
6 |
enterovirus |
6 |
flow cytometry |
6 |
h7n7 virus |
6 |
intestinal |
6 |
ire1 |
6 |
macrophages |
6 |
mdms |
6 |
middle aged |
6 |
mincle |
6 |
modcs |
6 |
mutation |
6 |
neurogenesis |
6 |
organoids |
6 |
pa protein |
6 |
platform |
6 |
proinflammatory response |
6 |
rlr |
6 |
spermatogenesis |
6 |
upr |
6 |
zika virus |
6 |
amino acid substitution - genetics |
5 |
antiviral peptide |
5 |
b cell |
5 |
b-lymphocytes - cytology - immunology - metabolism |
5 |
cell line |
5 |
cell line, tumor |
5 |
cell movement - immunology |
5 |
chemokine cxcl13 - biosynthesis - immunology |
5 |
chi-square distribution |
5 |
disease susceptibility |
5 |
down-regulation |
5 |
eif4g1 |
5 |
gene deletion |
5 |
gene expression profiling |
5 |
gene frequency |
5 |
genotype |
5 |
h5n1 influenza virus |
5 |
hela cells |
5 |
hepatitis b, chronic - genetics |
5 |
hepatitis b, chronic - genetics - virology |
5 |
host−virus interaction |
5 |
hsp90β |
5 |
ifngr1 |
5 |
il-17 |
5 |
influenza a virus, h5n1 subtype - immunology - pathogenicity |
5 |
influenza, human - immunology - pathology - virology |
5 |
interleukin-17 - deficiency - genetics - immunology |
5 |
logistic models |
5 |
luciferases - genetics - metabolism |
5 |
luminescent measurements |
5 |
lung - immunology - pathology - virology |
5 |
lung infection |
5 |
mice, inbred c57bl |
5 |
mice, knockout |
5 |
mutation, missense |
5 |
nucleoprotein |
5 |
odds ratio |
5 |
orthomyxoviridae infections - immunology - mortality - pathology - virology |
5 |
point mutation |
5 |
polymorphism, restriction fragment length |
5 |
promoter activity |
5 |
promoter regions, genetic - genetics |
5 |
protein stability |
5 |
receptor, interferon alpha-beta - biosynthesis - genetics |
5 |
receptors, cxcr5 - biosynthesis - immunology |
5 |
receptors, interferon - genetics |
5 |
sequence analysis, dna |
5 |
survival rate |
5 |
tat |
5 |
transfection |
5 |
weight loss |
5 |
adolescent |
4 |
antibodies, viral - blood |
4 |
antigens, cd55 - genetics - immunology |
4 |
asian continental ancestry group |
4 |
balb/c mice |
4 |
disease prevalence |
4 |
european continental ancestry group |
4 |
fluorescent antibody technique |
4 |
genetic susceptibility |
4 |
hepatitis b virus |
4 |
hong kong - epidemiology |
4 |
influenza a virus, h1n1 subtype - immunology - pathogenicity |
4 |
influenza, human - genetics - immunology - pathology - virology |
4 |
multifactor dimensionality reduction |
4 |
neutralization tests |
4 |
panenza vaccine |
4 |
pb2-k389r |
4 |
pb2-v598t/i |
4 |
pcr-rflp |
4 |
polymorphism, genetic |
4 |
sars virus - immunology |
4 |
severe acute respiratory syndrome - epidemiology - immunology - virology |
4 |
virulence |
4 |
virus-like particle |
4 |
h5n1 |
3 |
mammal |
3 |
receptor binding |
3 |
aged |
2 |
antiviral agents - metabolism - pharmacology - toxicity |
2 |
base sequence |
2 |
case-control studies |
2 |
cell communication |
2 |
cross protection |
2 |
cytokines - biosynthesis |
2 |
dendritic cells - immunology |
2 |
dna, viral - genetics |
2 |
dna-binding proteins - drug effects - genetics - physiology |
2 |
dogs |
2 |
gene expression regulation, viral - drug effects - physiology |
2 |
genes, mhc class ii |
2 |
hek293 cells |
2 |
hemagglutinin glycoproteins, influenza virus - chemistry - metabolism |
2 |
hepatitis b antibodies - blood |
2 |
hepatitis b vaccines - administration & dosage |
2 |
hepatitis b virus - genetics - isolation & purification |
2 |
hepatitis b virus - genetics - physiology |
2 |
hepatitis b, chronic - immunology - virology |
2 |
hydrocarbons, fluorinated - metabolism - pharmacology - toxicity |
2 |
immunoglobulin fc fragments - chemistry - immunology |
2 |
influenza a virus, h5n1 subtype - chemistry - immunology |
2 |
influenza a virus, h5n1 subtype - drug effects - metabolism - physiology |
2 |
influenza vaccines |
2 |
kruppel-like transcription factors - drug effects - genetics - physiology |
2 |
lymphocyte activation |
2 |
models, molecular |
2 |
monocytes - immunology |
2 |
nuclear proteins - drug effects - genetics - physiology |
2 |
piperidines - metabolism - pharmacology - toxicity |
2 |
protein conformation |
2 |
t-lymphocytes - immunology |
2 |
vaccines, synthetic - chemistry - immunology |
2 |
virus internalization - drug effects |
2 |